Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,257 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Erratum. Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study. Diabetes Care 2022;45:888-897.
Rossing P, Burgess E, Agarwal R, Anker SD, Filippatos G, Pitt B, Ruilope LM, Gillard P, MacIsaac RJ, Wainstein J, Joseph A, Brinker M, Roessig L, Scott C, Bakris GL; FIDELIO-DKD Investigators. Rossing P, et al. Among authors: agarwal r. Diabetes Care. 2023 Sep 1;46(9):1721. doi: 10.2337/dc23-er09. Diabetes Care. 2023. PMID: 37310695 Free PMC article. No abstract available.
Cardiorenal protective effects of canagliflozin in CREDENCE according to glucose lowering.
Charytan DM, Mahaffey KW, Jardine MJ, Cannon CP, Neal B, Lambers Heerspink HJ, Agarwal R, Bakris GL, de Zeeuw D, Levin A, Pollock C, Zhang H, Zinman B, Rosenthal N, Perkovic V, Di Tanna GL, Yu J, Rogers K, Arnott C, Wheeler DC. Charytan DM, et al. Among authors: agarwal r. BMJ Open Diabetes Res Care. 2023 Jun;11(3):e003270. doi: 10.1136/bmjdrc-2022-003270. BMJ Open Diabetes Res Care. 2023. PMID: 37311602 Free PMC article. Clinical Trial.
Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial.
Yi TW, Smyth B, Di Tanna GL, Arnott C, Cardoza K, Kang A, Pollock C, Agarwal R, Bakris G, Charytan DM, de Zeeuw D, Heerspink HJL, Neal B, Wheeler DC, Cannon CP, Zhang H, Zinman B, Perkovic V, Levin A, Mahaffey KW, Jardine M; CREDENCE Trial Investigators. Yi TW, et al. Among authors: agarwal r. Am J Kidney Dis. 2023 Jul;82(1):84-96.e1. doi: 10.1053/j.ajkd.2022.12.015. Epub 2023 Mar 7. Am J Kidney Dis. 2023. PMID: 36889425 Clinical Trial.
Role of ApoE polymorphism in Dementia.
Agarwal R, Kushwaha S, Tripathi CB. Agarwal R, et al. Alzheimers Dement. 2025 Jan 9;20(Suppl 2):e087829. doi: 10.1002/alz.087829. eCollection 2024 Dec. Alzheimers Dement. 2025. PMID: 39786307 Free PMC article.
Diuretics in patients with chronic kidney disease.
Agarwal R, Verma A, Georgianos PI. Agarwal R, et al. Nat Rev Nephrol. 2025 Jan 7. doi: 10.1038/s41581-024-00918-x. Online ahead of print. Nat Rev Nephrol. 2025. PMID: 39775051 Review.
Treatment of Established Chemotherapy-Induced Neuropathy with N-Palmitoylethanolamide: A Randomized, Double-Blind Phase II Pilot Study.
Davis MP, Ulrich A, Segal R, Gudena V, Ruddy KJ, D'Andre S, Giridhar KV, Vasireddy VK, Agarwal R, Azzouqa AG, Novotny P, McCue S, Bauer B, Loprinzi CL. Davis MP, et al. Among authors: agarwal r. Cancers (Basel). 2024 Dec 20;16(24):4244. doi: 10.3390/cancers16244244. Cancers (Basel). 2024. PMID: 39766143 Free PMC article.
Structure-Based Design of Small-Molecule Inhibitors of Human Interleukin-6.
Joshi A, Xiao Z, Suman S, Cooper C, Ha K, Agarwal R, Carson JA, Quarles LD, Smith JC, Gupta M. Joshi A, et al. Among authors: agarwal r. bioRxiv [Preprint]. 2024 Dec 26:2024.12.26.630392. doi: 10.1101/2024.12.26.630392. bioRxiv. 2024. PMID: 39763828 Free PMC article. Preprint.
4,257 results